Showing results (161-170 of 202) with videos related to
Sort By:
Pageof 21
European Journal of Dermatology : EJD|December 3, 2019
Memory CD4+ T cells lacking expression of CCR7 promote pro-inflammatory cytokine production in patients with diffuse cutaneous systemic sclerosisGiovanni Almanzar, Marc Schmalzing, Matthias Klein, et al.Cancers|June 16, 2019
Uveal Melanoma: A European Network to Face the Many Challenges of a Rare CancerSophie Piperno-Neumann, Jose Maria Piulats, Matthias Goebeler, et al.JCI Insight|April 29, 2025
Epac1 contributes to apremilast-mediated rescue of pemphigus autoantibody-induced loss of keratinocyte adhesionAnna M Sigmund, Franziska C Bayerbach, Daniela Kugelmann, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 8, 2020
COVID-19 and immunological regulations - from basic and translational aspects to clinical implicationsMichael P Schön, Carola Berking, Tilo Biedermann, et al.Frontiers in Immunology|December 27, 2021
NFAT5 Controls the Integrity of EpidermisKhalid Muhammad, Delicia Xavier, Stefan Klein-Hessling, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 4, 2007
Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseasesDetlef Zillikens, Kurt Derfler, Rüdiger Eming, et al.Expert Review of Clinical Immunology|April 29, 2025
Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseasesKelly G Gwathmey, Catherine M Broome, Matthias Goebeler, et al.Cancers|May 11, 2024
Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood NeutrophilsSimone Wendlinger, Jonas Wohlfarth, Claudia Siedel, et al.International Journal of Molecular Sciences|August 14, 2025
Influence of a Th17-Inducing Cytokine Milieu on Phenotypical and Functional Properties of Regulatory T Cells in Chronic Inflammatory ArthritisTobias Schwarz, Giovanni Almanzar, Marie Wulfheide, et al.Cancer|December 19, 2018
The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomasSilke Appenzeller, Anja Gesierich, Alexander Thiem, et al.Pageof 21